21 results for author:"Larochelle W.J." in Literature citations
Results Customize
› Repeat search in UniProtKB (12)
| Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix. Kalinina J., Byron S.A., Makarenkova H.P., Olsen S.K., Eliseenkova A.V., Larochelle W.J., Dhanabal M., Blais S., Ornitz D.M., Day L.A. et al. Mol. Cell. Biol. 29:4663-4678(2009) · UniProtKB (1) · Mapped (2) |
| FGFR2IIIb signaling regulates thymic epithelial differentiation. Dooley J., Erickson M., Larochelle W.J., Gillard G.O., Farr A.G. Dev. Dyn. 236:3459-3471(2007) · Mapped (43) |
| A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. Ostendorf T., van Roeyen C.R.C., Peterson J.D., Kunter U., Eitner F., Hamad A.J., Chan G., Jia X.-C., Macaluso J., Gazit-Bornstein G. et al. J. Am. Soc. Nephrol. 14:2237-2247(2003) · UniProtKB (1) |
| Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer. LaRochelle W.J., Jeffers M., Corvalan J.R.F., Jia X.-C., Feng X., Vanegas S., Vickroy J.D., Yang X.-D., Chen F., Gazit G. et al. Cancer Res. 62:2468-2473(2002) · UniProtKB (2) |
| PDGF D, a novel protease-activated growth factor. LaRochelle W.J., Jeffers M., McDonald W.F., Chillakuru R.A., Giese N.A., Lokker N.A., Sullivan C., Boldog F.L., Yang M., Vernet C. et al. Nat. Cell Biol. 3:517-521(2001) · UniProtKB (3) |
| Ulcerative proctitis, rectal prolapse, and intestinal pseudo-obstruction in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Takayama H., Takagi H., Larochelle W.J., Kapur R.P., Merlino G. Lab. Invest. 81:297-305(2001) · Mapped (3) |
| Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis. Jeffers M., Shimkets R., Prayaga S., Boldog F., Yang M., Burgess C., Fernandes E., Rittman B., Shimkets J., LaRochelle W.J. et al. Cancer Res. 61:3131-3138(2001) · UniProtKB (1) |
| Isolation and characterization of a novel PDGF-induced human gene. Nelson S.A., Santora K.E., LaRochelle W.J. |
| Multiple growth factor induction of a murine early response gene that complements a lethal defect in yeast ribosome biogenesis. Nelson S.A., Aris J.P., Patel B.K., LaRochelle W.J. J. Biol. Chem. 275:13835-13841(2000) · Mapped (1) |
| Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Otsuka T., Jakubczak J., Vieira W., Bottaro D.P., Breckenridge D., Larochelle W.J., Merlino G. Mol. Cell. Biol. 20:2055-2065(2000) · Mapped (3) |
| Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts. Kriebel P., Patel B.K., Nelson S.A., Grusby M.J., LaRochelle W.J. Oncogene 18:7294-7302(1999) · Mapped (4) |
| Localization of the human stat6 gene to chromosome 12q13.3-q14.1, a region implicated in multiple solid tumors. Patel B.K., Keck C.L., O'Leary R.S., Popescu N.C., LaRochelle W.J. Genomics 52:192-200(1998) · UniProtKB (1) |
| Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. Celli G., LaRochelle W.J., Mackem S., Sharp R., Merlino G. EMBO J. 17:1642-1655(1998) · Mapped (54) |
| NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo. Jakubczak J.L., LaRochelle W.J., Merlino G. Mol. Cell. Biol. 18:1275-1283(1998) · UniProtKB (1) · Mapped (2) |
| Cloning and characterization of the mouse homolog of the human A6 gene. Beeler J.F., Patel B.K.R., Chedid M., LaRochelle W.J. |
| Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas. Diez de Medina S.G., Chopin D., El Marjou A., Delouvee A., LaRochelle W.J., Hoznek A., Abbou C., Aaronson S.A., Thiery J.P., Radvanyi F. Oncogene 14:323-330(1997) · Mapped (8) |
| Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Takayama H., LaRochelle W.J., Sharp R., Otsuka T., Kriebel P., Anver M., Aaronson S.A., Merlino G. Proc. Natl. Acad. Sci. U.S.A. 94:701-706(1997) · Mapped (3) |
| Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Sakata H., Takayama H., Sharp R., Rubin J.S., Merlino G., LaRochelle W.J. Cell Growth Differ. 7:1513-1523(1996) · Mapped (3) |
| Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to alpha and beta PDGF receptor. Fretto L.J., Snape A.J., Tomlinson J.E., Seroogy J.J., Wolf D.L., LaRochelle W.J., Giese N.A. J. Biol. Chem. 268:3625-3631(1993) · UniProtKB (2) |
| Prokaryotic expression cloning of a novel human tyrosine kinase. Beeler J.F., LaRochelle W.J., Chedid M., Tronick S.R., Aaronson S.A. Mol. Cell. Biol. 14:982-988(1994) · UniProtKB (1) |
| Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. Matsui T., Pierce J.H., Fleming T.P., Greenberger J.S., LaRochelle W.J., Ruggiero M., Aaronson S.A. Proc. Natl. Acad. Sci. U.S.A. 86:8314-8318(1989) · UniProtKB (2) |